Correction: Clinical validation of full HR-HPV genotyping HPV Selfy assay according to the international guidelines for HPV test requirements for cervical cancer screening on clinician-collected and self-collected samples

Affiliations

• ¹ Ulisse BioMed S.p.A, Area Science Park, SS 14, km 163.5, Trieste, Italy.
• ² Molecular Genetics and Biotechnology PhD Study Programme, University of Nova Gorica, Nova Gorica, Slovenia.
• ³ Ginecologia Oncologica, IRCCS-Centro Di Riferimento Oncologico (CRO) (Istituto Nazionale Tumori-National Cancer Institute), Aviano, Italy.
• ⁴ Azienda Sanitaria Universitaria Giuliano Isontina UCO/ SC Anatomia e Istologia Patologica, Cattinara Hospital, Trieste, Italy.
• ⁵ Department of Medicine, Surgery and Health Sciences, University of Trieste, Trieste, Italy.
• ⁶ Anatomia Patologica, IRCCS-CRO (Istituto Nazionale Tumori - National Cancer Institute), Aviano, Italy.
• ⁷ Institut Ruđer Bošković, Zagreb, Croatia.
• ⁸ Policlinico Universitario Campus Biomedico, Rome, Italy.
• ⁹ Copan Italia S.p.A., via F. Perotti 10, 25125, Brescia, Italy.
• ¹⁰ Institute of Maternal and Child Health, IRCCS Burlo Garofolo, Trieste, Italy.
• ¹¹ Clinical Research Unit, Azienda Sanitaria Universitaria Giuliano Isontina, Trieste, Italy.
• ¹² Cervical Cancer Screening Coordination Unit, Azienda Sanitaria Universitaria Giuliano Isontina, Trieste, Italy.
• ¹³ International Centre for Genetic Engineering and Biotechnology, Trieste, Italy.
• ¹⁴ Ulisse BioMed S.p.A, Area Science Park, SS 14, km 163.5, Trieste, Italy. r.ippodrino@ulissebiomed.com.